Wearable Health-tech Provider Appoints Dr Pamela Peeke New CMO; Welcomes 2 New Board Members

Bone Health Technologies (BHT), a leading innovator of technologies for improving bone health and preventing bone diseases, names Dr Pamela Peeke as the new Chief Medical Officer and board member and appoints two new board members: Dr. Kian Beyzavi and Marcie Hamilton. The addition of these talented professionals will enhance BHT’s product, research, and commercial growth capabilities.

“Building on the exciting results from our pivotal trial showing statistically significant benefit for vertebral bone strength and bone density, we are investing in strengthening the medical and commercial organization,” said Laura Yecies, CEO of BHT. “Dr. Peeke’s expertise in and approach to longevity and women’s health are consistent with our vision for bringing a safe, non-pharmacological, clinically-proven solution to the tens of millions of people with low bone density.  We are thrilled to have her as part of the team. Additionally, Dr. Beyzavi and Ms. Hamilton bring deep medical device development and commercialization experience to BHT.”

Dr Pamela Peeke is a clinical scientist, Pew Foundation Scholar in Nutrition and Metabolism, Assistant Professor of Medicine at the University of Maryland, and holds master’s degrees in public health and policy from the University of California Berkeley. Dr. Peeke is a nationally recognized expert in women’s health, menopause, and longevity.  She is a member of the National Menopause Foundation Medical Advisory Board and a Trustee on the American College of Sports Medicine Board. In addition to providing in-studio medical commentaries for national networks, Dr. Peeke is an acclaimed TEDx presenter, three-time New York Times bestselling author, and host of the top-rated HER podcast. Dr. Peeke will join Bone Health Technology’s board in addition to serving as its Chief Medical Officer.

Dr. Kian Beyzavi and Marcie Hamilton join BHT as board directors. Dr. Kian Beyzavi earned her PhD in Electrical Engineering/Applied Physics from Princeton University. Her work focuses on solutions that marry dynamic data and AI and machine learning to drive advances in patient care with a system-level view of the healthcare landscape. Over the past 20 years, Dr. Beyzavi has played a key role in developing multiple MedTech, Digital Health, and Biopharma products across 60 companies. She started her career at McKinsey & Company and has held senior executive positions at Medtronic, Abbott Diabetes, and Novartis Diagnostics. She has also been a venture investor, advisor, and board member for significant medical companies like Inflammatix, Vave Health, Excision, and ActiveSurgical. Dr. Beyzavi is a Council on Foreign Relations member and a California Academy of Sciences trustee.

Marcie Hamilton is a program and operations leader in medical devices and consumer products. After earning her B.S. in Mechanical Engineering from Purdue University, Hamilton became the sole program manager at VivaRay Inc., making significant contributions that led to an acquisition by Varian Medical Systems. More recently, she co-founded Potrero Medical, which developed a predictive technology platform for early detection of critical illnesses.

BHT will continue to advance the treatment of osteoporosis and osteopenia with the addition of these skilled women within the female-led Company.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy